These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 20578137)
21. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis. Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896 [No Abstract] [Full Text] [Related]
22. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state. Kraszewski JN; Kay DM; Stevens CF; Koval C; Haser B; Ortiz V; Albertorio A; Cohen LL; Jain R; Andrew SP; Young SD; LaMarca NM; De Vivo DC; Caggana M; Chung WK Genet Med; 2018 Jun; 20(6):608-613. PubMed ID: 29758563 [TBL] [Abstract][Full Text] [Related]
23. SMN1 dosage analysis in spinal muscular atrophy from India. Kesari A; Rennert H; Leonard DG; Mittal B BMC Med Genet; 2005 May; 6():22. PubMed ID: 15910686 [TBL] [Abstract][Full Text] [Related]
24. Spinal muscular atrophy carriers with two SMN1 copies. Ar Rochmah M; Awano H; Awaya T; Harahap NIF; Morisada N; Bouike Y; Saito T; Kubo Y; Saito K; Lai PS; Morioka I; Iijima K; Nishio H; Shinohara M Brain Dev; 2017 Nov; 39(10):851-860. PubMed ID: 28676237 [TBL] [Abstract][Full Text] [Related]
25. [Spinal muscular atrophy carrier frequency in Ukraine]. Solov'ev AA; Grishchenko NV; Livshits LA Genetika; 2013 Sep; 49(9):1126-8. PubMed ID: 25486782 [TBL] [Abstract][Full Text] [Related]
26. Spinal muscular atrophy carrier frequency and estimated prevalence of the disease in Moroccan newborns. Lyahyai J; Sbiti A; Barkat A; Ratbi I; Sefiani A Genet Test Mol Biomarkers; 2012 Mar; 16(3):215-8. PubMed ID: 21950724 [TBL] [Abstract][Full Text] [Related]
27. Carrier frequency of SMN1-related spinal muscular atrophy in north Indian population: The need for population based screening program. Nilay M; Moirangthem A; Saxena D; Mandal K; Phadke SR Am J Med Genet A; 2021 Jan; 185(1):274-277. PubMed ID: 33051992 [TBL] [Abstract][Full Text] [Related]
28. Enhanced Carrier Screening for Spinal Muscular Atrophy: Detection of Silent (SMN1: 2 + 0) Carriers Utilizing a Novel TaqMan Genotyping Method. Azad AK; Huang CK; Jin H; Zou H; Yanakakis L; Du J; Fiddler M; Naeem R; Goldstein Y Lab Med; 2020 Jul; 51(4):408-415. PubMed ID: 31875889 [TBL] [Abstract][Full Text] [Related]
29. Detection of Spinal Muscular Atrophy Using a Duplexed Real-Time PCR Approach With Locked Nucleic Acid-Modified Primers. Pan J; Zhang C; Teng Y; Zeng S; Chen S; Liang D; Li Z; Wu L Ann Lab Med; 2021 Jan; 41(1):101-107. PubMed ID: 32829585 [TBL] [Abstract][Full Text] [Related]
30. Population screening and cascade testing for carriers of SMA. Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705 [TBL] [Abstract][Full Text] [Related]
31. A single strand conformation polymorphism-based carrier test for spinal muscular atrophy. Semprini S; Tacconelli A; Capon F; Brancati F; Dallapiccola B; Novelli G Genet Test; 2001; 5(1):33-7. PubMed ID: 11336398 [TBL] [Abstract][Full Text] [Related]
33. [Clinical practice guidelines for spinal muscular atrophy]. Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Pan J; Tan H; Zhou M; Liang D; Wu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):263-268. PubMed ID: 32128742 [TBL] [Abstract][Full Text] [Related]
34. [Results of carrier screening for Spinal muscular atrophy among 35 145 reproductive-aged individuals from Dongguan region]. Zhao Y; Lou J; Fu Y; Dai Y; Liang Q; Sun M; Tan J; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jun; 40(6):655-660. PubMed ID: 37211998 [TBL] [Abstract][Full Text] [Related]
35. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Ogino S; Wilson RB Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240 [TBL] [Abstract][Full Text] [Related]
36. Utility of two SMN1 variants to improve spinal muscular atrophy carrier diagnosis and genetic counselling. Alías L; Bernal S; Calucho M; Martínez E; March F; Gallano P; Fuentes-Prior P; Abuli A; Serra-Juhe C; Tizzano EF Eur J Hum Genet; 2018 Oct; 26(10):1554-1557. PubMed ID: 29904179 [TBL] [Abstract][Full Text] [Related]
38. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel. Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318 [TBL] [Abstract][Full Text] [Related]
39. The clinical utility of a risk-modifying SNP to detect carriers for spinal muscular atrophy with increased sensitivity. Ware G; Miller C; Jones D; Avenarius M Mol Genet Genomic Med; 2022 Apr; 10(4):e1897. PubMed ID: 35289093 [TBL] [Abstract][Full Text] [Related]
40. [A pilot study on spinal muscular atrophy carrier screening in Shanghai region using real-time PCR]. Qu XX; Xiao B; Ji X; Jiang WT; Yang ZJ; Tao J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):1-4. PubMed ID: 23450468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]